scispace - formally typeset
Open AccessJournal ArticleDOI

Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53

Reads0
Chats0
TLDR
The presence of functional p53 response elements on the Type II hexokinase promoter and the positive regulatory effect on the promoter by the mutant p53 indicates that in rapidly growing liver tumors, and perhaps in many other tumors as well, this highly abundant p53 protein plays a role in maintaining a high glycolytic rate.
About
This article is published in Journal of Biological Chemistry.The article was published on 1997-09-05 and is currently open access. It has received 248 citations till now. The article focuses on the topics: Hexokinase & Glycolysis.

read more

Citations
More filters
Journal ArticleDOI

Why do cancers have high aerobic glycolysis

TL;DR: In this article, the authors propose that persistent metabolism of glucose to lactate even in aerobic conditions is an adaptation to intermittent hypoxia in pre-malignant lesions, which leads to microenvironmental acidosis requiring evolution to phenotypes resistant to acid-induced cell toxicity.
Journal ArticleDOI

Regulation of cancer cell metabolism

TL;DR: Interest in the topic of tumour metabolism has waxed and waned over the past century, but it has become clear that many of the signalling pathways that are affected by genetic mutations and the tumour microenvironment have a profound effect on core metabolism, making this topic once again one of the most intense areas of research in cancer biology.
Journal ArticleDOI

RAS oncogenes: weaving a tumorigenic web

TL;DR: This Review describes how RAS oncogenes exploit their extensive signalling reach to affect multiple cellular processes that drive tumorigenesis.
Journal ArticleDOI

Glycolysis inhibition for anticancer treatment

TL;DR: The increased dependence of cancer cells on glycolytic pathway for ATP generation provides a biochemical basis for the design of therapeutic strategies to preferentially kill cancer cells by pharmacological inhibition of Glycolysis.
Journal ArticleDOI

Oncogenic alterations of metabolism.

TL;DR: Over seven decades of classical biochemical studies showed that tumors have altered metabolic profiles and display high rates of glucose uptake and glycolysis, which might confer a common advantage on many different types of cancers, which allows the cells to survive and invade.
References
More filters
Journal ArticleDOI

DNA sequencing with chain-terminating inhibitors

TL;DR: A new method for determining nucleotide sequences in DNA is described, which makes use of the 2',3'-dideoxy and arabinon nucleoside analogues of the normal deoxynucleoside triphosphates, which act as specific chain-terminating inhibitors of DNA polymerase.
Journal ArticleDOI

Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors

TL;DR: New Escherichia coli host strains have been constructed for the E. coli bacteriophage M13 and the high-copy-number pUC-plasmid cloning vectors and mutations introduced into these strains improve cloning of unmodified DNA and of repetitive sequences.
Journal ArticleDOI

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

TL;DR: A procedure for preparing extracts from nuclei of human tissue culture cells that directs accurate transcription initiation in vitro from class II promoters, including tRNA and Ad 2 VA, is developed.
Journal ArticleDOI

p53 mutations in human cancers

TL;DR: The p53 mutational spectrum differs among cancers of the colon, lung, esophagus, breast, liver, brain, reticuloendothelial tissues, and hemopoietic tissues as mentioned in this paper.
Book

Culture of Animal Cells

TL;DR: Biology of Cultured Cells, Design and Layout, and Organotypic Culture: Problems Solving.
Related Papers (5)